A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device

NCT02098265 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2026-05-15

No results posted yet for this study

Summary

The purpose of this research is to determine if two non-invasive brain stimulation techniques, muscle stimulation of the arm and neuro-stimulation through the tongue, can increase the extent of stroke recovery.

Conditions

Interventions

DEVICE

Functional Electric Stimulation (FES)

FES uses low energy electrical pulses to artificially generate body movements in individuals with muscle paralysis. FES can be used to generate muscle contraction in otherwise paralyzed limbs to restore function.

BEHAVIORAL

Behavioral Assessments

These assessments will include measures of upper extremity motor assessments, standard stroke scales, and measures of activities of daily living.

OTHER

Magnetic Resonance Imaging

A functional magnetic resonance image will be collected.

OTHER

EEG

EEG electrodes will be attached to the participant's scalp using a standard, commercially available electrode cap. Proper electrode placement is made according to the international 10-20 system, ensuring complete electrode coverage over sensorimotor cortex.

OTHER

RecoveriX

RecoveriX is a brain driven rehabilitation system for stroke patients that pairs mental activities with motor functions.

OTHER

Delay

10 week delay before intervention

DEVICE

BCI-FES

Sponsors & Collaborators

Principal Investigators

  • Vivek Prabhakaran, MD, PhD · University of Wisconsin, Madison

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2027-06-30
Completion
2027-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02098265 on ClinicalTrials.gov